E-LIB Suche - Ergebnisse für: Morimoto, Daishi

1

STING activator 2′3′‐cGAMP enhanced HSV‐1‐based oncolytic v..:

Sibal, Patricia Angela ; Matsumura, Shigeru ; Ichinose, Toru...
Molecular Oncology. 18 (2024) 5 - p. 1259-1277 , 2024

Link: https://doi.org/10.1002/..

2

C-REV Retains High Infectivity Regardless of the Expression..:

Morimoto, Daishi ; Matsumura, Shigeru ; Bustos-Villalobos, Itzel...
Cells. 10 (2021) 6 - p. 1502 , 2021

Link: https://doi.org/10.3390/..

3

Oncolytic herpes simplex virusHF10(canerpaturev) promotes a..:

Eissa, Ibrahim Ragab ; Mukoyama, Nobuaki ; Abdelmoneim, Mohamed...
International Journal of Cancer. 149 (2021) 1 - p. 214-227 , 2021

Link: https://doi.org/10.1002/..

4

Comparison of non‐invasive liver reserve and fibrosis model..:

Sonohara, Fuminori ; Yamada, Suguru ; Tanaka, Nobutake...
Hepatology Research. 49 (2019) 11 - p. 1305-1315 , 2019

Link: https://doi.org/10.1111/..

5

Novel Prognostic Implications of DUPAN-2 in the Era of Init..:

Sunagawa, Yuki ; Yamada, Suguru ; Sato, Yusuke...
Annals of Surgical Oncology. 27 (2019) 6 - p. 2081-2089 , 2019

Link: https://doi.org/10.1245/..

6

Combination of Cetuximab and Oncolytic Virus Canerpaturev S..:

Wu, Zhiwen ; Ichinose, Toru ; Naoe, Yoshinori...
Molecular Therapy - Oncolytics. 13 (2019) - p. 107-115 , 2019

Link: https://doi.org/10.1016/..

7

The Current Status and Future Prospects of Oncolytic Viruse..:

Eissa, Ibrahim ; Bustos-Villalobos, Itzel ; Ichinose, Toru...
Cancers. 10 (2018) 10 - p. 356 , 2018

Link: https://doi.org/10.3390/..

8

Analysis of predictive factors for portal and splenic vein ..:

Tanaka, Nobutake ; Fujii, Tsutomu ; Yamada, Suguru...
Pancreatology. 17 (2017) 4 - p. S6-S7 , 2017

Link: https://doi.org/10.1016/..

9

S-1 facilitates canerpaturev (C-REV)-induced antitumor effi..:

Miyajima, Noriyuki ; Ragab Eissa, Ibrahim ; Abdelmoneim, Mohamed...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648537/. , 2021

Link: http://www.ncbi.nlm.nih...

10

S-1 facilitates canerpaturev (C-REV)-induced antitumor effi..:

Miyajima, Noriyuki ; Ragab Eissa, Ibrahim ; Abdelmoneim, Mohamed...
https://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/834.html. , 2021

Link: https://nagoya.repo.nii...

11

Combination of Cetuximab and Oncolytic Virus Canerpaturev S..:

Wu, Zhiwen ; Ichinose, Toru ; Naoe, Yoshinori...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539424/. , 2019

Link: http://www.ncbi.nlm.nih...

12

C-REV Retains High Infectivity Regardless of the Expression..:

Daishi Morimoto ; Shigeru Matsumura ; Itzel Bustos-Villalobos...
https://www.mdpi.com/2073-4409/10/6/1502. , 2021

Link: https://doi.org/10.3390/..

13

C-REV Retains High Infectivity Regardless of the Expression..:

Daishi Morimoto ; Shigeru Matsumura ; Itzel Bustos-Villalobos...
Cell and Gene Therapy. , 2021

Link: https://doi.org/10.3390/..

14

Combination of Cetuximab and Oncolytic Virus Canerpaturev S..:

Zhiwen Wu ; Toru Ichinose ; Yoshinori Naoe...
http://www.sciencedirect.com/science/article/pii/S237277051930052X. , 2019

Link: https://doi.org/10.1016/..

15

The Current Status and Future Prospects of Oncolytic Viruse..:

Ibrahim Eissa ; Itzel Bustos-Villalobos ; Toru Ichinose...
https://dx.doi.org/10.3390/cancers10100356. , 2018

Link: https://doi.org/10.3390/..